BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15450772)

  • 1. MRI evaluation of treatment of embolic stroke in rat with intra-arterial and intravenous rt-PA.
    Jiang Q; Zhang ZG; Zhang L; Ding GL; Li L; Ewing JR; Lu M; Whitton P; Hu J; Li QJ; Zhang RL; Chopp M
    J Neurol Sci; 2004 Sep; 224(1-2):57-67. PubMed ID: 15450772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging indexes of therapeutic efficacy of recombinant tissue plasminogen activator treatment of rat at 1 and 4 hours after embolic stroke.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Jiang P; Divine GW; Knight RA; Chopp M
    J Cereb Blood Flow Metab; 2000 Jan; 20(1):21-7. PubMed ID: 10616789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric ISODATA analysis of embolic stroke and rt-PA intervention in rat.
    Ding G; Jiang Q; Zhang L; Zhang Z; Knight RA; Soltanian-Zadeh H; Lu M; Ewing JR; Li Q; Whitton PA; Chopp M
    J Neurol Sci; 2004 Aug; 223(2):135-43. PubMed ID: 15337614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging characterization of hemorrhagic transformation of embolic stroke in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Knight RA; Ewing JR; Ding G; Lu M; Arniego P; Zhang L; Hu J; Li Q; Chopp M
    J Cereb Blood Flow Metab; 2002 May; 22(5):559-68. PubMed ID: 11973428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study.
    Kollmar R; Henninger N; Bardutzky J; Schellinger PD; Schäbitz WR; Schwab S
    Exp Neurol; 2004 Nov; 190(1):204-12. PubMed ID: 15473993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model.
    Okubo S; Igarashi H; Kanamatsu T; Hasegawa D; Orima H; Katayama Y
    Brain Res; 2007 Apr; 1143():221-7. PubMed ID: 17316578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
    Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
    J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new rat model of thrombotic focal cerebral ischemia.
    Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
    Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
    Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].
    Kirchhof K; Sikinger M; Welzel T; Zoubaa S; Sartor K
    Rofo; 2004 Jan; 176(1):98-105. PubMed ID: 14712413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cerebral tissue by MRI map ISODATA in embolic stroke in rat.
    Ding G; Jiang Q; Li L; Zhang L; Zhang ZG; Soltanian-Zadeh H; Li Q; Whitton PA; Ewing JR; Chopp M
    Brain Res; 2006 Apr; 1084(1):202-9. PubMed ID: 16566903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of neural progenitor cell induced angiogenesis after embolic stroke in rat using MRI.
    Jiang Q; Zhang ZG; Ding GL; Zhang L; Ewing JR; Wang L; Zhang R; Li L; Lu M; Meng H; Arbab AS; Hu J; Li QJ; Pourabdollah Nejad D S; Athiraman H; Chopp M
    Neuroimage; 2005 Nov; 28(3):698-707. PubMed ID: 16112879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
    Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
    J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance angiography of thromboembolic stroke in rats: indicator of recanalization probability and tissue survival after recombinant tissue plasminogen activator treatment.
    Hilger T; Niessen F; Diedenhofen M; Hossmann KA; Hoehn M
    J Cereb Blood Flow Metab; 2002 Jun; 22(6):652-62. PubMed ID: 12045663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infarct prediction and treatment assessment with MRI-based algorithms in experimental stroke models.
    Wu O; Sumii T; Asahi M; Sasamata M; Ostergaard L; Rosen BR; Lo EH; Dijkhuizen RM
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):196-204. PubMed ID: 16685257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.